No­vo, As­cendis to work on month­ly GLP-1; KalVista makes a roy­al­ty deal

Plus, news about Disc Med­i­cine, OSE Im­munother­a­peu­tics, Cross­Bridge Bio, Lomond Ther­a­peu­tics, Re­lief Ther­a­peu­tics and Renexxion:

No­vo Nordisk, As­cendis Phar­ma ink deal: The Dan­ish drug­mak­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER